APO Research
Talk to an analyst

APO RESEARCH · REPORT

Pravastatin

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Pravastatin Industry Growth and Trends Forecast to 2032

20 December 2025114 pages

Choose your research edition.

Industry ResearchPravastatin Industry Research Report 2026139 pages · $2,950 USDIndustry Growth & TrendsGlobal Pravastatin Industry Growth and Trends Forecast to 2032114 pages · $3,450 USDMarket StructureGlobal Pravastatin Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032194 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Pravastatin Market Outlook and Growth Opportunities 2026209 pages · $4,250 USDMarket Analysis & ForecastGlobal Pravastatin Market Analysis and Forecast 2026-2032209 pages · $4,950 USD

Market perspective

The global Pravastatin market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Pravastatin is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Pravastatin is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Pravastatin is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Pravastatin include TEVA, Shanghai Shyndec Pharmaceutical, SANDOZ, Mylan, Jiangxi Boyaseehot Pharmaceutical, North China Pharmaceutical Group, Zydus Pharmaceuticals, Upsher-Smith Laboratories and Lupin Pharmaceuticals, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Pravastatin market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Pravastatin market size, estimates, and forecasts are presented in terms of sales volume (W Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Pravastatin market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Pravastatin.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Pravastatin market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Pravastatin Market by Company

TEVA

Shanghai Shyndec Pharmaceutical

SANDOZ

Mylan

Jiangxi Boyaseehot Pharmaceutical

North China Pharmaceutical Group

Zydus Pharmaceuticals

Upsher-Smith Laboratories

Lupin Pharmaceuticals

Hisun

Glenmark

Dr. Reddy's Laboratories

Daiichi Sankyo

Cipla Inc.

Bristol-Myers Squibb

Aurobindo Pharma

APOTEX

Accord Healthcare

Pravastatin Segment by Type

10mg Tablet

20mg Tablet

40mg Tablet

80mg Tablet

Pravastatin Segment by Application

Adults

Children

Pravastatin Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pravastatin market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Pravastatin and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pravastatin.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Pravastatin manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Pravastatin in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of 10mg Tablet Table 2. Major Company of 20mg Tablet Table 3. Major Company of 40mg Tablet Table 4. Major Company of 80mg Tablet Table 5. Global Pravastatin Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 6. Global Pravastatin Sales by Type (2021-2026) & (W Units) Table 7. Global Pravastatin Sales Market Share in Volume by Type (2021-2026) Table 8. Global Pravastatin Sales by Type (2021-2026) & (US$ Million) Table 9. Global Pravastatin Sales Market Share in Value by Type (2021-2026) Table 10. Global Pravastatin Price by Type (2021-2026) & (US$/Unit) Table 11. Global Pravastatin Sales by Type (2027-2032) & (W Units) Table 12. Global Pravastatin Sales Market Share in Volume by Type (2027-2032) Table 13. Global Pravastatin Sales by Type (2027-2032) & (US$ Million) Table 14. Global Pravastatin Sales Market Share in Value by Type (2027-2032) Table 15. Global Pravastatin Price by Type (2027-2032) & (US$/Unit) Table 16. North America Pravastatin Sales by Type (2021-2026) & (W Units) Table 17. North America Pravastatin Sales by Type (2021-2026) & (US$ Million) Table 18. Europe Pravastatin Sales by Type (2021-2026) & (W Units) Table 19. Europe Pravastatin Sales by Type (2021-2026) & (US$ Million) Table 20. Asia-Pacific Pravastatin Sales by Type (2021-2026) & (W Units) Table 21. Asia-Pacific Pravastatin Sales by Type (2021-2026) & (US$ Million) Table 22. Latin America Pravastatin Sales by Type (2021-2026) & (W Units) Table 23. Latin America Pravastatin Sales by Type (2021-2026) & (US$ Million) Table 24. Middle East and Africa Pravastatin Sales by Type (2021-2026) & (W Units) Table 25. Middle East and Africa Pravastatin Sales by Type (2021-2026) & (US$ Million) Table 26. Pravastatin Industry Trends Table 27. Pravastatin Industry Drivers Table 28. Pravastatin Industry Opportunities and Challenges Table 29. Pravastatin Industry Restraints Table 30. Global Pravastatin Sales Revenue by Company (US$ Million) & (2021-2026) Table 31. Global Pravastatin Revenue Market Share by Company (2021-2026) Table 32. Global Pravastatin Sales by Company (2021-2026) & (W Units) Table 33. Global Pravastatin Sales Share by Company (2021-2026) Table 34. Global Pravastatin Market Price by Company (2021-2026) & (US$/Unit) Table 35. Global Pravastatin Industry Company Ranking, 2024 VS 2025 VS 2026 Table 36. Global Pravastatin Major Company Production Sites and Headquarters Table 37. Global Pravastatin Company, Product Type & Application Table 38. Global Pravastatin Company Establishment Date Table 39. Global Company Market Concentration Ratio (CR5 and HHI) Table 40. Global Pravastatin by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 41. Global Pravastatin Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 42. Global Pravastatin Sales by Region (2021-2026) & (W Units) Table 43. Global Pravastatin Sales Market Share in Volume by Region (2021-2026) Table 44. Global Pravastatin Sales by Region (2021-2026) & (US$ Million) Table 45. Global Pravastatin Sales Market Share in Value by Region (2021-2026) Table 46. Global Pravastatin Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 47. Global Pravastatin Sales by Region (2027-2032) & (W Units) Table 48. Global Pravastatin Sales Market Share in Volume by Region (2027-2032) Table 49. Global Pravastatin Sales by Region (2027-2032) & (US$ Million) Table 50. Global Pravastatin Sales Market Share in Value by Region (2027-2032) Table 51. Global Pravastatin Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 52. Global Pravastatin Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 53. Global Pravastatin Sales by Application (2021-2026) & (W Units) Table 54. Global Pravastatin Sales Market Share in Volume by Application (2021-2026) Table 55. Global Pravastatin Sales by Application (2021-2026) & (US$ Million) Table 56. Global Pravastatin Sales Market Share in Value by Application (2021-2026) Table 57. Global Pravastatin Price by Application (2021-2026) & (US$/Unit) Table 58. Global Pravastatin Sales by Application (2027-2032) & (W Units) Table 59. Global Pravastatin Sales Market Share in Volume by Application (2027-2032) Table 60. Global Pravastatin Sales by Application (2027-2032) & (US$ Million) Table 61. Global Pravastatin Sales Market Share in Value by Application (2027-2032) Table 62. Global Pravastatin Price by Application (2027-2032) & (US$/Unit) Table 63. North America Pravastatin Sales by Application (2021-2026) & (W Units) Table 64. North America Pravastatin Sales by Application (2021-2026) & (US$ Million) Table 65. Europe Pravastatin Sales by Application (2021-2026) & (W Units) Table 66. Europe Pravastatin Sales by Application (2021-2026) & (US$ Million) Table 67. Asia-Pacific Pravastatin Sales by Application (2021-2026) & (W Units) Table 68. Asia-Pacific Pravastatin Sales by Application (2021-2026) & (US$ Million) Table 69. Latin America Pravastatin Sales by Application (2021-2026) & (W Units) Table 70. Latin America Pravastatin Sales by Application (2021-2026) & (US$ Million) Table 71. Middle East and Africa Pravastatin Sales by Application (2021-2026) & (W Units) Table 72. Middle East and Africa Pravastatin Sales by Application (2021-2026) & (US$ Million) Table 73. TEVA Company Information Table 74. TEVA Business Overview Table 75. TEVA Pravastatin Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 76. TEVA Pravastatin Product Portfolio Table 77. TEVA Recent Development Table 78. Shanghai Shyndec Pharmaceutical Company Information Table 79. Shanghai Shyndec Pharmaceutical Business Overview Table 80. Shanghai Shyndec Pharmaceutical Pravastatin Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 81. Shanghai Shyndec Pharmaceutical Pravastatin Product Portfolio Table 82. Shanghai Shyndec Pharmaceutical Recent Development Table 83. SANDOZ Company Information Table 84. SANDOZ Business Overview Table 85. SANDOZ Pravastatin Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 86. SANDOZ Pravastatin Product Portfolio Table 87. SANDOZ Recent Development Table 88. Mylan Company Information Table 89. Mylan Business Overview Table 90. Mylan Pravastatin Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 91. Mylan Pravastatin Product Portfolio Table 92. Mylan Recent Development Table 93. Jiangxi Boyaseehot Pharmaceutical Company Information Table 94. Jiangxi Boyaseehot Pharmaceutical Business Overview Table 95. Jiangxi Boyaseehot Pharmaceutical Pravastatin Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 96. Jiangxi Boyaseehot Pharmaceutical Pravastatin Product Portfolio Table 97. Jiangxi Boyaseehot Pharmaceutical Recent Development Table 98. North China Pharmaceutical Group Company Information Table 99. North China Pharmaceutical Group Business Overview Table 100. North China Pharmaceutical Group Pravastatin Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 101. North China Pharmaceutical Group Pravastatin Product Portfolio Table 102. North China Pharmaceutical Group Recent Development Table 103. Zydus Pharmaceuticals Company Information Table 104. Zydus Pharmaceuticals Business Overview Table 105. Zydus Pharmaceuticals Pravastatin Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 106. Zydus Pharmaceuticals Pravastatin Product Portfolio Table 107. Zydus Pharmaceuticals Recent Development Table 108. Upsher-Smith Laboratories Company Information Table 109. Upsher-Smith Laboratories Business Overview Table 110. Upsher-Smith Laboratories Pravastatin Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 111. Upsher-Smith Laboratories Pravastatin Product Portfolio Table 112. Upsher-Smith Laboratories Recent Development Table 113. Lupin Pharmaceuticals Company Information Table 114. Lupin Pharmaceuticals Business Overview Table 115. Lupin Pharmaceuticals Pravastatin Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 116. Lupin Pharmaceuticals Pravastatin Product Portfolio Table 117. Lupin Pharmaceuticals Recent Development Table 118. Hisun Company Information Table 119. Hisun Business Overview Table 120. Hisun Pravastatin Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 121. Hisun Pravastatin Product Portfolio Table 122. Hisun Recent Development Table 123. Glenmark Company Information Table 124. Glenmark Business Overview Table 125. Glenmark Pravastatin Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 126. Glenmark Pravastatin Product Portfolio Table 127. Glenmark Recent Development Table 128. Dr. Reddy's Laboratories Company Information Table 129. Dr. Reddy's Laboratories Business Overview Table 130. Dr. Reddy's Laboratories Pravastatin Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 131. Dr. Reddy's Laboratories Pravastatin Product Portfolio Table 132. Dr. Reddy's Laboratories Recent Development Table 133. Daiichi Sankyo Company Information Table 134. Daiichi Sankyo Business Overview Table 135. Daiichi Sankyo Pravastatin Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 136. Daiichi Sankyo Pravastatin Product Portfolio Table 137. Daiichi Sankyo Recent Development Table 138. Cipla Inc. Company Information Table 139. Cipla Inc. Business Overview Table 140. Cipla Inc. Pravastatin Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 141. Cipla Inc. Pravastatin Product Portfolio Table 142. Cipla Inc. Recent Development Table 143. Bristol-Myers Squibb Company Information Table 144. Bristol-Myers Squibb Business Overview Table 145. Bristol-Myers Squibb Pravastatin Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 146. Bristol-Myers Squibb Pravastatin Product Portfolio Table 147. Bristol-Myers Squibb Recent Development Table 148. Aurobindo Pharma Company Information Table 149. Aurobindo Pharma Business Overview Table 150. Aurobindo Pharma Pravastatin Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 151. Aurobindo Pharma Pravastatin Product Portfolio Table 152. Aurobindo Pharma Recent Development Table 153. APOTEX Company Information Table 154. APOTEX Business Overview Table 155. APOTEX Pravastatin Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 156. APOTEX Pravastatin Product Portfolio Table 157. APOTEX Recent Development Table 158. Accord Healthcare Company Information Table 159. Accord Healthcare Business Overview Table 160. Accord Healthcare Pravastatin Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 161. Accord Healthcare Pravastatin Product Portfolio Table 162. Accord Healthcare Recent Development Table 163. North America Pravastatin Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 164. North America Pravastatin Sales by Country (2021-2026) & (W Units) Table 165. North America Pravastatin Sales Market Share by Country (2021-2026) Table 166. North America Pravastatin Sales Forecast by Country (2027-2032) & (W Units) Table 167. North America Pravastatin Sales Market Share Forecast by Country (2027-2032) Table 168. North America Pravastatin Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 169. North America Pravastatin Market Size by Country (2021-2026) & (US$ Million) Table 170. North America Pravastatin Market Share by Country (2021-2026) Table 171. North America Pravastatin Market Size Forecast by Country (2027-2032) & (US$ Million) Table 172. North America Pravastatin Market Share Forecast by Country (2027-2032) Table 173. Europe Pravastatin Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 174. Europe Pravastatin Sales by Country (2021-2026) & (W Units) Table 175. Europe Pravastatin Sales Market Share by Country (2021-2026) Table 176. Europe Pravastatin Sales Forecast by Country (2027-2032) & (W Units) Table 177. Europe Pravastatin Sales Market Share Forecast by Country (2027-2032) Table 178. Europe Pravastatin Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 179. Europe Pravastatin Market Size by Country (2021-2026) & (US$ Million) Table 180. Europe Pravastatin Market Share by Country (2021-2026) Table 181. Europe Pravastatin Market Size Forecast by Country (2027-2032) & (US$ Million) Table 182. Europe Pravastatin Market Share Forecast by Country (2027-2032) Table 183. Asia-Pacific Pravastatin Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 184. Asia-Pacific Pravastatin Sales by Country (2021-2026) & (W Units) Table 185. Asia-Pacific Pravastatin Sales Market Share by Country (2021-2026) Table 186. Asia-Pacific Pravastatin Sales Forecast by Country (2027-2032) & (W Units) Table 187. Asia-Pacific Pravastatin Sales Market Share Forecast by Country (2027-2032) Table 188. Asia-Pacific Pravastatin Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 189. Asia-Pacific Pravastatin Market Size by Country (2021-2026) & (US$ Million) Table 190. Asia-Pacific Pravastatin Market Share by Country (2021-2026) Table 191. Asia-Pacific Pravastatin Market Size Forecast by Country (2027-2032) & (US$ Million) Table 192. Asia-Pacific Pravastatin Market Share Forecast by Country (2027-2032) Table 193. Latin America Pravastatin Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 194. Latin America Pravastatin Sales by Country (2021-2026) & (W Units) Table 195. Latin America Pravastatin Sales Market Share by Country (2021-2026) Table 196. Latin America Pravastatin Sales Forecast by Country (2027-2032) & (W Units) Table 197. Latin America Pravastatin Sales Market Share Forecast by Country (2027-2032) Table 198. Latin America Pravastatin Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 199. Latin America Pravastatin Market Size by Country (2021-2026) & (US$ Million) Table 200. Latin America Pravastatin Market Share by Country (2021-2026) Table 201. Latin America Pravastatin Market Size Forecast by Country (2027-2032) & (US$ Million) Table 202. Latin America Pravastatin Market Share Forecast by Country (2027-2032) Table 203. Middle East and Africa Pravastatin Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 204. Middle East and Africa Pravastatin Sales by Country (2021-2026) & (W Units) Table 205. Middle East and Africa Pravastatin Sales Market Share by Country (2021-2026) Table 206. Middle East and Africa Pravastatin Sales Forecast by Country (2027-2032) & (W Units) Table 207. Middle East and Africa Pravastatin Sales Market Share Forecast by Country (2027-2032) Table 208. Middle East and Africa Pravastatin Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 209. Middle East and Africa Pravastatin Market Size by Country (2021-2026) & (US$ Million) Table 210. Middle East and Africa Pravastatin Market Share by Country (2021-2026) Table 211. Middle East and Africa Pravastatin Market Size Forecast by Country (2027-2032) & (US$ Million) Table 212. Middle East and Africa Pravastatin Market Share Forecast by Country (2027-2032) Table 213. Key Raw Materials Table 214. Raw Materials Key Suppliers Table 215. Pravastatin Distributors List Table 216. Pravastatin Customers List Table 217. Research Programs/Design for This Report Table 218. Authors List of This Report Table 219. Secondary Sources Table 220. Primary Sources List of Figures Figure 1. Pravastatin Image Figure 2. Global Pravastatin Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Pravastatin Market Size (2021-2032) & (US$ Million) Figure 4. Global Pravastatin Sales (2021-2032) & (W Units) Figure 5. 10mg Tablet Image Figure 6. Global 10mg Tablet Sales YoY Growth (2021-2032) & (W Units) Figure 7. 20mg Tablet Image Figure 8. Global 20mg Tablet Sales YoY Growth (2021-2032) & (W Units) Figure 9. 40mg Tablet Image Figure 10. Global 40mg Tablet Sales YoY Growth (2021-2032) & (W Units) Figure 11. 80mg Tablet Image Figure 12. Global 80mg Tablet Sales YoY Growth (2021-2032) & (W Units) Figure 13. Global Pravastatin Market Size Overview by Type (2021-2032) & (US$ Million) Figure 14. Global Pravastatin Market Share by Type 2025 VS 2032 Figure 15. North America Pravastatin Sales Market Share in Volume by Type in 2025 Figure 16. North America Pravastatin Sales Market Share in Value by Type in 2025 Figure 17. Europe Pravastatin Sales Market Share in Volume by Type in 2025 Figure 18. Europe Pravastatin Sales Market Share in Value by Type in 2025 Figure 19. Asia-Pacific Pravastatin Sales Market Share in Volume by Type in 2025 Figure 20. Asia-Pacific Pravastatin Sales Market Share in Value by Type in 2025 Figure 21. Latin America Pravastatin Sales Market Share in Volume by Type in 2025 Figure 22. Latin America Pravastatin Sales Market Share in Value by Type in 2025 Figure 23. Middle East and Africa Pravastatin Sales Market Share in Volume by Type in 2025 Figure 24. Middle East and Africa Pravastatin Sales Market Share in Value by Type in 2025 Figure 25. Global Top 5 and 10 Pravastatin Players Market Share by Revenue in 2025 Figure 26. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 27. Adults Image Figure 28. Global Adults Sales YoY Growth (2021-2032) & (W Units) Figure 29. Children Image Figure 30. Global Children Sales YoY Growth (2021-2032) & (W Units) Figure 31. Global Pravastatin Market Size Overview by Application (2021-2032) & (US$ Million) Figure 32. Global Pravastatin Market Share by Application 2025 VS 2032 Figure 33. North America Pravastatin Sales Market Share in Volume by Application in 2025 Figure 34. North America Pravastatin Sales Market Share in Value by Application in 2025 Figure 35. Europe Pravastatin Sales Market Share in Volume by Application in 2025 Figure 36. Europe Pravastatin Sales Market Share in Value by Application in 2025 Figure 37. Asia-Pacific Pravastatin Sales Market Share in Volume by Application in 2025 Figure 38. Asia-Pacific Pravastatin Sales Market Share in Value by Application in 2025 Figure 39. Latin America Pravastatin Sales Market Share in Volume by Application in 2025 Figure 40. Latin America Pravastatin Sales Market Share in Value by Application in 2025 Figure 41. Middle East and Africa Pravastatin Sales Market Share in Volume by Application in 2025 Figure 42. Middle East and Africa Pravastatin Sales Market Share in Value by Application in 2025 Figure 43. North America Pravastatin Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 44. North America Pravastatin Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. North America Pravastatin Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. North America Pravastatin Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Pravastatin Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 48. Europe Pravastatin Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Pravastatin Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Europe Pravastatin Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Pravastatin Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 52. Asia-Pacific Pravastatin Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Pravastatin Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Asia-Pacific Pravastatin Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Pravastatin Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 56. Latin America Pravastatin Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Pravastatin Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Latin America Pravastatin Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Pravastatin Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 60. Middle East and Africa Pravastatin Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Pravastatin Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Middle East and Africa Pravastatin Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Pravastatin Value Chain Figure 64. Key Raw Materials Price Figure 65. Manufacturing Cost Structure Figure 66. Pravastatin Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • 10mg Tablet
  • 20mg Tablet
  • 40mg Tablet
  • 80mg Tablet
Applications
  • Adults
  • Children
Companies covered
  • TEVA
  • Shanghai Shyndec Pharmaceutical
  • SANDOZ
  • Mylan
  • Jiangxi Boyaseehot Pharmaceutical
  • North China Pharmaceutical Group
  • Zydus Pharmaceuticals
  • Upsher-Smith Laboratories
  • Lupin Pharmaceuticals
  • Hisun
  • Glenmark
  • Dr. Reddy's Laboratories
  • Daiichi Sankyo
  • Cipla Inc.
  • Bristol-Myers Squibb
  • Aurobindo Pharma
  • APOTEX
  • Accord Healthcare

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Pravastatin Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Pravastatin Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Pravastatin Market by Type
  6. 1.3.1 10mg Tablet
  7. 1.3.2 20mg Tablet
  8. 1.3.3 40mg Tablet
  9. 1.3.4 80mg Tablet
  10. 1.4 Global Pravastatin Market Size by Type
  11. 1.4.1 Global Pravastatin Market Size Overview by Type (2021-2032)
  12. 1.4.2 Global Pravastatin Historic Market Size Review by Type (2021-2026)
  13. 1.4.3 Global Pravastatin Forecasted Market Size by Type (2027-2032)
  14. 1.5 Key Regions Market Size by Type
  15. 1.5.1 North America Pravastatin Sales Breakdown by Type (2021-2026)
  16. 1.5.2 Europe Pravastatin Sales Breakdown by Type (2021-2026)
  17. 1.5.3 Asia-Pacific Pravastatin Sales Breakdown by Type (2021-2026)
  18. 1.5.4 South America Pravastatin Sales Breakdown by Type (2021-2026)
  19. 1.5.5 Middle East and Africa Pravastatin Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Pravastatin Industry Trends
  2. 2.2 Pravastatin Industry Drivers
  3. 2.3 Pravastatin Industry Opportunities and Challenges
  4. 2.4 Pravastatin Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Pravastatin Revenue (2021-2026)
  2. 3.2 Global Top Players by Pravastatin Sales (2021-2026)
  3. 3.3 Global Top Players by Pravastatin Price (2021-2026)
  4. 3.4 Global Pravastatin Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Pravastatin Major Company Production Sites & Headquarters
  6. 3.6 Global Pravastatin Company, Product Type & Application
  7. 3.7 Global Pravastatin Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Pravastatin Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Pravastatin Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Pravastatin Tier 1, Tier 2, and Tier 3
4 Pravastatin Regional Status and Outlook
  1. 4.1 Global Pravastatin Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Pravastatin Historic Market Size by Region
  3. 4.2.1 Global Pravastatin Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Pravastatin Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Pravastatin Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Pravastatin Forecasted Market Size by Region
  7. 4.3.1 Global Pravastatin Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Pravastatin Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Pravastatin Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Pravastatin by Application
  1. 5.1 Pravastatin Market by Application
  2. 5.1.1 Adults
  3. 5.1.2 Children
  4. 5.2 Global Pravastatin Market Size by Application
  5. 5.2.1 Global Pravastatin Market Size Overview by Application (2021-2032)
  6. 5.2.2 Global Pravastatin Historic Market Size Review by Application (2021-2026)
  7. 5.2.3 Global Pravastatin Forecasted Market Size by Application (2027-2032)
  8. 5.3 Key Regions Market Size by Application
  9. 5.3.1 North America Pravastatin Sales Breakdown by Application (2021-2026)
  10. 5.3.2 Europe Pravastatin Sales Breakdown by Application (2021-2026)
  11. 5.3.3 Asia-Pacific Pravastatin Sales Breakdown by Application (2021-2026)
  12. 5.3.4 South America Pravastatin Sales Breakdown by Application (2021-2026)
  13. 5.3.5 Middle East and Africa Pravastatin Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 TEVA
  2. 6.1.1 TEVA Company Information
  3. 6.1.2 TEVA Business Overview
  4. 6.1.3 TEVA Pravastatin Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 TEVA Pravastatin Product Portfolio
  6. 6.1.5 TEVA Recent Developments
  7. 6.2 Shanghai Shyndec Pharmaceutical
  8. 6.2.1 Shanghai Shyndec Pharmaceutical Company Information
  9. 6.2.2 Shanghai Shyndec Pharmaceutical Business Overview
  10. 6.2.3 Shanghai Shyndec Pharmaceutical Pravastatin Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Shanghai Shyndec Pharmaceutical Pravastatin Product Portfolio
  12. 6.2.5 Shanghai Shyndec Pharmaceutical Recent Developments
  13. 6.3 SANDOZ
  14. 6.3.1 SANDOZ Company Information
  15. 6.3.2 SANDOZ Business Overview
  16. 6.3.3 SANDOZ Pravastatin Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 SANDOZ Pravastatin Product Portfolio
  18. 6.3.5 SANDOZ Recent Developments
  19. 6.4 Mylan
  20. 6.4.1 Mylan Company Information
  21. 6.4.2 Mylan Business Overview
  22. 6.4.3 Mylan Pravastatin Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Mylan Pravastatin Product Portfolio
  24. 6.4.5 Mylan Recent Developments
  25. 6.5 Jiangxi Boyaseehot Pharmaceutical
  26. 6.5.1 Jiangxi Boyaseehot Pharmaceutical Company Information
  27. 6.5.2 Jiangxi Boyaseehot Pharmaceutical Business Overview
  28. 6.5.3 Jiangxi Boyaseehot Pharmaceutical Pravastatin Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Jiangxi Boyaseehot Pharmaceutical Pravastatin Product Portfolio
  30. 6.5.5 Jiangxi Boyaseehot Pharmaceutical Recent Developments
  31. 6.6 North China Pharmaceutical Group
  32. 6.6.1 North China Pharmaceutical Group Company Information
  33. 6.6.2 North China Pharmaceutical Group Business Overview
  34. 6.6.3 North China Pharmaceutical Group Pravastatin Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 North China Pharmaceutical Group Pravastatin Product Portfolio
  36. 6.6.5 North China Pharmaceutical Group Recent Developments
  37. 6.7 Zydus Pharmaceuticals
  38. 6.7.1 Zydus Pharmaceuticals Company Information
  39. 6.7.2 Zydus Pharmaceuticals Business Overview
  40. 6.7.3 Zydus Pharmaceuticals Pravastatin Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Zydus Pharmaceuticals Pravastatin Product Portfolio
  42. 6.7.5 Zydus Pharmaceuticals Recent Developments
  43. 6.8 Upsher-Smith Laboratories
  44. 6.8.1 Upsher-Smith Laboratories Company Information
  45. 6.8.2 Upsher-Smith Laboratories Business Overview
  46. 6.8.3 Upsher-Smith Laboratories Pravastatin Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Upsher-Smith Laboratories Pravastatin Product Portfolio
  48. 6.8.5 Upsher-Smith Laboratories Recent Developments
  49. 6.9 Lupin Pharmaceuticals
  50. 6.9.1 Lupin Pharmaceuticals Company Information
  51. 6.9.2 Lupin Pharmaceuticals Business Overview
  52. 6.9.3 Lupin Pharmaceuticals Pravastatin Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Lupin Pharmaceuticals Pravastatin Product Portfolio
  54. 6.9.5 Lupin Pharmaceuticals Recent Developments
  55. 6.10 Hisun
  56. 6.10.1 Hisun Company Information
  57. 6.10.2 Hisun Business Overview
  58. 6.10.3 Hisun Pravastatin Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Hisun Pravastatin Product Portfolio
  60. 6.10.5 Hisun Recent Developments
  61. 6.11 Glenmark
  62. 6.11.1 Glenmark Company Information
  63. 6.11.2 Glenmark Business Overview
  64. 6.11.3 Glenmark Pravastatin Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Glenmark Pravastatin Product Portfolio
  66. 6.11.5 Glenmark Recent Developments
  67. 6.12 Dr. Reddy's Laboratories
  68. 6.12.1 Dr. Reddy's Laboratories Company Information
  69. 6.12.2 Dr. Reddy's Laboratories Business Overview
  70. 6.12.3 Dr. Reddy's Laboratories Pravastatin Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 Dr. Reddy's Laboratories Pravastatin Product Portfolio
  72. 6.12.5 Dr. Reddy's Laboratories Recent Developments
  73. 6.13 Daiichi Sankyo
  74. 6.13.1 Daiichi Sankyo Company Information
  75. 6.13.2 Daiichi Sankyo Business Overview
  76. 6.13.3 Daiichi Sankyo Pravastatin Sales, Revenue and Gross Margin (2021-2026)
  77. 6.13.4 Daiichi Sankyo Pravastatin Product Portfolio
  78. 6.13.5 Daiichi Sankyo Recent Developments
  79. 6.14 Cipla Inc.
  80. 6.14.1 Cipla Inc. Company Information
  81. 6.14.2 Cipla Inc. Business Overview
  82. 6.14.3 Cipla Inc. Pravastatin Sales, Revenue and Gross Margin (2021-2026)
  83. 6.14.4 Cipla Inc. Pravastatin Product Portfolio
  84. 6.14.5 Cipla Inc. Recent Developments
  85. 6.15 Bristol-Myers Squibb
  86. 6.15.1 Bristol-Myers Squibb Company Information
  87. 6.15.2 Bristol-Myers Squibb Business Overview
  88. 6.15.3 Bristol-Myers Squibb Pravastatin Sales, Revenue and Gross Margin (2021-2026)
  89. 6.15.4 Bristol-Myers Squibb Pravastatin Product Portfolio
  90. 6.15.5 Bristol-Myers Squibb Recent Developments
  91. 6.16 Aurobindo Pharma
  92. 6.16.1 Aurobindo Pharma Company Information
  93. 6.16.2 Aurobindo Pharma Business Overview
  94. 6.16.3 Aurobindo Pharma Pravastatin Sales, Revenue and Gross Margin (2021-2026)
  95. 6.16.4 Aurobindo Pharma Pravastatin Product Portfolio
  96. 6.16.5 Aurobindo Pharma Recent Developments
  97. 6.17 APOTEX
  98. 6.17.1 APOTEX Company Information
  99. 6.17.2 APOTEX Business Overview
  100. 6.17.3 APOTEX Pravastatin Sales, Revenue and Gross Margin (2021-2026)
  101. 6.17.4 APOTEX Pravastatin Product Portfolio
  102. 6.17.5 APOTEX Recent Developments
  103. 6.18 Accord Healthcare
  104. 6.18.1 Accord Healthcare Company Information
  105. 6.18.2 Accord Healthcare Business Overview
  106. 6.18.3 Accord Healthcare Pravastatin Sales, Revenue and Gross Margin (2021-2026)
  107. 6.18.4 Accord Healthcare Pravastatin Product Portfolio
  108. 6.18.5 Accord Healthcare Recent Developments
7 North America by Country
  1. 7.1 North America Pravastatin Sales by Country
  2. 7.1.1 North America Pravastatin Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Pravastatin Sales by Country (2021-2026)
  4. 7.1.3 North America Pravastatin Sales Forecast by Country (2027-2032)
  5. 7.2 North America Pravastatin Market Size by Country
  6. 7.2.1 North America Pravastatin Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Pravastatin Market Size by Country (2021-2026)
  8. 7.2.3 North America Pravastatin Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Pravastatin Sales by Country
  2. 8.1.1 Europe Pravastatin Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Pravastatin Sales by Country (2021-2026)
  4. 8.1.3 Europe Pravastatin Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Pravastatin Market Size by Country
  6. 8.2.1 Europe Pravastatin Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Pravastatin Market Size by Country (2021-2026)
  8. 8.2.3 Europe Pravastatin Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Pravastatin Sales by Country
  2. 9.1.1 Asia-Pacific Pravastatin Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Pravastatin Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Pravastatin Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Pravastatin Market Size by Country
  6. 9.2.1 Asia-Pacific Pravastatin Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Pravastatin Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Pravastatin Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Pravastatin Sales by Country
  2. 10.1.1 South America Pravastatin Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Pravastatin Sales by Country (2021-2026)
  4. 10.1.3 South America Pravastatin Sales Forecast by Country (2027-2032)
  5. 10.2 South America Pravastatin Market Size by Country
  6. 10.2.1 South America Pravastatin Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Pravastatin Market Size by Country (2021-2026)
  8. 10.2.3 South America Pravastatin Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Pravastatin Sales by Country
  2. 11.1.1 Middle East and Africa Pravastatin Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Pravastatin Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Pravastatin Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Pravastatin Market Size by Country
  6. 11.2.1 Middle East and Africa Pravastatin Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Pravastatin Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Pravastatin Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Pravastatin Value Chain Analysis
  2. 12.1.1 Pravastatin Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Pravastatin Production Mode & Process
  7. 12.2 Pravastatin Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Pravastatin Distributors
  10. 12.2.3 Pravastatin Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst